US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cross Timbers Royalty

10.09

+0.06000.60%

Post-market: 10.090.00000.00%19:23 EDT

Volume:68.41K

Turnover:694.31K

Market Cap:60.54M

PE:10.14

High:10.38

Open:10.19

Low:10.00

Close:10.03

Loading ...

Overview Company News Filings

EBR Systems Launches First Commercial Implants of WiSE CRT System in the US

Cross Timbers Royalty Trust Reports Q1 Distributable Income of $1.78M, $0.297 EPS

Analysts Offer Insights on Energy Companies: Tamarack Valley Energy (OtherTNEYF), Suncor Energy (SU) and Cross Timbers Royalty (CRT)

Analysts’ Opinions Are Mixed on These Energy Stocks: MEG Energy (OtherMEGEF), Spartan Delta (OtherDALXF) and Cross Timbers Royalty (CRT)

EBR Systems Targets $3.6 Billion Market on Commercial Launch, Shares Slump 12%

MT Newswires Live

Press Release: CROSS TIMBERS ROYALTY TRUST DECLARES MAY CASH DISTRIBUTION

Press Release: Innate Pharma Reports First Quarter 2025 Business Update and Financial Results

Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware

KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Why Cross Timbers Royalty Trust (CRT) Is Losing This Week

PennyMac Mortgage Investment Trust Reports First Quarter 2025 Results

FDA Approves WiSE® System, World's First and Only Leadless Left Ventricular Endocardial Pacing (LVEP) Device for CRT

Press Release: CROSS TIMBERS ROYALTY TRUST DECLARES APRIL CASH DISTRIBUTION

Which ASX company has just secured FDA approval?

Australian Shares Rise Amidst Temporary Reprieve for Electronic Tariffs; EBR Systems Receives US FDA Approval for Heart Failure Treatment Device

MT Newswires Live

U.S. Food and Drug Administration Approves Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a Treatment for Patients with Previously Untreated Microsatellite Instability-High or Mismatch Repair Deficient Unresectable or Metastatic Colorectal Cancer1

IMFINZI® (durvalumab) approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer

Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications

New study results reinforce TAGRISSO® (osimertinib) as the backbone therapy for EGFR-mutated lung cancer across stages and settings

EBR Systems Advances Towards FDA Approval and Market Launch of WiSE CRT System

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CRT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CRT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRT\",,,,,undefined,":{"symbol":"CRT","market":"US","secType":"STK","nameCN":"Cross Timbers Royalty","latestPrice":10.09,"timestamp":1749844800000,"preClose":10.03,"halted":0,"volume":68405,"hourTrading":{"tag":"盘后","latestPrice":10.09,"preClose":10.09,"latestTime":"19:23 EDT","volume":103,"amount":1042.77,"timestamp":1749856983658},"delay":0,"floatShares":5999764,"shares":6000000,"eps":0.994757,"marketStatus":"Market Closed","change":0.06,"latestTime":"06-13 16:00:00 EDT","open":10.19,"high":10.3796,"low":10,"amount":694313.554605,"amplitude":0.037846,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.994757,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750060800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":699253200000,"exchange":"NYSE","adjPreClose":10.03,"dividendRate":0.098588,"preHourTrading":{"tag":"盘前","latestPrice":10.39,"preClose":10.0879,"latestTime":"08:36 EDT","volume":54,"amount":560.890008,"timestamp":1749818176516},"postHourTrading":{"tag":"盘后","latestPrice":10.09,"preClose":10.09,"latestTime":"19:23 EDT","volume":103,"amount":1042.77,"timestamp":1749856983658},"volumeRatio":3.7880298084171793},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRT\",,,,,undefined,":{"symbol":"CRT","floatShares":5999764,"roa":"92.98%","roe":"240.32%","lyrEps":0.946303,"volumeRatio":3.7880298084171793,"shares":6000000,"dividePrice":0.994757,"high":10.3796,"amplitude":0.037846,"preClose":10.03,"low":10,"week52Low":8.8801,"pbRate":"25.80","psRate":"8.86","week52High":13.3119,"institutionHeld":0.0264,"latestPrice":10.09,"eps":0.994757,"divideRate":0.098588,"volume":68405,"delay":0,"ttmEps":0.994757,"open":10.19,"prevYearClose":9.9,"prevWeekClose":9.75,"prevMonthClose":9.97,"prevQuarterClose":13.17,"fiveDayClose":9.75,"twentyDayClose":10,"sixtyDayClose":10.855},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CRT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541004102","title":"EBR Systems Launches First Commercial Implants of WiSE CRT System in the US","url":"https://stock-news.laohu8.com/highlight/detail?id=2541004102","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541004102?lang=en_us&edition=fundamental","pubTime":"2025-06-06 07:38","pubTimestamp":1749166734,"startTime":"0","endTime":"0","summary":"EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( ($AU:EBR) ) has provided an announcement. EBR Systems, Inc. has successfully completed...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ebr-systems-launches-first-commercial-implants-of-wise-crt-system-in-the-us?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ebr-systems-launches-first-commercial-implants-of-wise-crt-system-in-the-us?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B1B80R65.USD","EBR","BK4213","CRT","BK4081"],"gpt_icon":0},{"id":"2541953960","title":"Cross Timbers Royalty Trust Reports Q1 Distributable Income of $1.78M, $0.297 EPS","url":"https://stock-news.laohu8.com/highlight/detail?id=2541953960","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541953960?lang=en_us&edition=fundamental","pubTime":"2025-06-05 02:44","pubTimestamp":1749062697,"startTime":"0","endTime":"0","summary":"Cross Timbers Royalty Trust reported its financial results for the first quarter of 2025. The trust declared a distributable income of $1.784 million, which was paid out in distributions over the months of February, March, and April 2025. This represents an increase from the $1.493 million distributed in the same period the previous year. The trust's corpus at the end of the period was $2.347 million, down from $2.621 million at the end of the first quarter of 2024. Gross income per unit for the first quarter totaled $0.379635, with deductions for severance taxes and administration expenses bringing the net to $0.297323 per unit of beneficial interest. The trust's assets included cash and short-term investments amounting to $1.937 million as of March 31, 2025, an increase from $1.369 million at the end of 2024. The increase in cash and short-term investments is attributed to the interest income of $12,006 received during the quarter. No specific outlook or guidance for future performan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDLccxTf8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Cross Timbers Royalty Trust Reports Q1 Distributable Income of $1.78M, $0.297 EPS","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRT"],"gpt_icon":0},{"id":"2538111763","title":"Analysts Offer Insights on Energy Companies: Tamarack Valley Energy (OtherTNEYF), Suncor Energy (SU) and Cross Timbers Royalty (CRT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2538111763","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538111763?lang=en_us&edition=fundamental","pubTime":"2025-05-25 17:04","pubTimestamp":1748163875,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Energy sector with new ratings on Tamarack Valley Energy (TNEYF – Research Report), Suncor Energy (SU –...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-energy-companies-tamarack-valley-energy-othertneyf-suncor-energy-su-and-cross-timbers-royalty-crt?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-energy-companies-tamarack-valley-energy-othertneyf-suncor-energy-su-and-cross-timbers-royalty-crt?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRT","BK4213","BK4201","LU0300736492.USD","LU0300736062.USD","BK4585","SU"],"gpt_icon":0},{"id":"2538211175","title":"Analysts’ Opinions Are Mixed on These Energy Stocks: MEG Energy (OtherMEGEF), Spartan Delta (OtherDALXF) and Cross Timbers Royalty (CRT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2538211175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538211175?lang=en_us&edition=fundamental","pubTime":"2025-05-25 17:02","pubTimestamp":1748163765,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Energy sector with new ratings on MEG Energy (MEGEF – Research Report), Spartan Delta (DALXF – Research...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-energy-stocks-meg-energy-othermegef-spartan-delta-otherdalxf-and-cross-timbers-royalty-crt?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-energy-stocks-meg-energy-othermegef-spartan-delta-otherdalxf-and-cross-timbers-royalty-crt?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRT","SPAQ.U","MEG","LU2308191902.HKD","BK4120","BK4213"],"gpt_icon":0},{"id":"2537993213","title":"EBR Systems Targets $3.6 Billion Market on Commercial Launch, Shares Slump 12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537993213","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537993213?lang=en_us&edition=fundamental","pubTime":"2025-05-22 13:16","pubTimestamp":1747891015,"startTime":"0","endTime":"0","summary":"EBR Systems  is targeting an around $3.6 billion initial addressable market at the commercial launch of its Wireless Stimulation Endocardially  Cardiac Resynchronisation Therapy  system, according to a Thursday Australian bourse filing.The firm submitted its application to the US Centers for Medicare & Medicaid Services for the transitional pass-through reimbursement scheme for its proprietary WiSE CRT system.The biggest segment in the initial addressable market is expected to be patients for whom the traditional CRT system implant has ceased to provide effective CRT. This segment represents $1.45 billion.High-risk patients and patients with a leadless right ventricle pacemaker are also part of the firm's initial addressable market. Medtronic's Micra leadless pacemaker has been qualified for use with the WiSE CRT system.The firm's shares slumped 12% in recent trading on Thursday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","EBR.AU","EBR","IE00B1B80R65.USD","BK4213","BK4081","CRT"],"gpt_icon":0},{"id":"2536689163","title":"Press Release: CROSS TIMBERS ROYALTY TRUST DECLARES MAY CASH DISTRIBUTION","url":"https://stock-news.laohu8.com/highlight/detail?id=2536689163","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536689163?lang=en_us&edition=fundamental","pubTime":"2025-05-19 20:00","pubTimestamp":1747656000,"startTime":"0","endTime":"0","summary":"DALLAS, May 19, 2025 /PRNewswire/ -- Argent Trust Company, as Trustee of the Cross Timbers Royalty Trust  , today declared a cash distribution to the holders of its units of beneficial interest of $0.080799 per unit, payable on June 13, 2025, to unitholders of record on May 30, 2025. The following table shows underlying oil and gas sales and average prices attributable to the current month and prior month distributions.  Sales volumes are recorded in the month the Trust receives the related. net profits income. Because of this, sales volumes may fluctuate from. In accordance with Section 3.08 of the Cross Timbers Royalty Trust Indenture, the Trustee has withheld $50,000 from this month's distribution to increase the amount of cash in the reserve account. The Trustee intends to continue to withhold $50,000 from distributable funds per month until the cash reserve has reached $1,500,000.For more information on the Trust, including the annual tax information, distribution amounts, and his","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","CRT","CASH","BK4211"],"gpt_icon":0},{"id":"2535764426","title":"Press Release: Innate Pharma Reports First Quarter 2025 Business Update and Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2535764426","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535764426?lang=en_us&edition=fundamental","pubTime":"2025-05-13 13:00","pubTimestamp":1747112400,"startTime":"0","endTime":"0","summary":"-- EUR15 million investment by Sanofi, in addition to the ongoing. partnership including the development of BCMA targeting ANKET program. -- First patient dosed in a Phase 1 study for IPH4502, Nectin-4 ADC in. patients with selected advanced solid tumors. Presentations at AACR. -- FDA Breakthrough Therapy Designation granted to lacutamab for relapsed or. refractory Sézary syndrome; long term follow up data from TELLOMAK. Phase 2 to be presented at ASCO Annual Meeting 2025. ANKET is Innate's proprietary platform for developing next-generation, multi-specific NK cell engagers to treat certain types of cancer.The Phase 1/2 clinical trial evaluating IPH6501 in B-cell Non-Hodgkin's lymphoma  is ongoing. The study is planned to enroll up t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","CRT","IPHYF","BK4139","IPHA","R","BK4213","BK4232"],"gpt_icon":0},{"id":"2531869477","title":"Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware","url":"https://stock-news.laohu8.com/highlight/detail?id=2531869477","media":"Business Wire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531869477?lang=en_us&edition=fundamental","pubTime":"2025-04-29 18:45","pubTimestamp":1745923500,"startTime":"0","endTime":"0","summary":"Merck Wilmington Biotech will serve as a launch and commercial production facility and the future U.S. home for KEYTRUDA. RAHWAY, N.J., April 29, 2025----Merck , known as MSD outside of the United States and Canada, announced today the start of construction for a $1 billion, 470,000-square-foot state-of-the-art biologics center of excellence in Wilmington, Delaware.A cornerstone of Merck’s continued commitment to investing in American innovation and infrastructure, Merck Wilmington Biotech will comprise laboratory, manufacturing and warehouse capabilities to enable the launch and commercial production of next-generation biologics and therapies including potent antibody-drug conjugates , reinforcing Merck’s focus on expanding and diversifying its pipeline.With proximity to Delaware and Pennsylvania universities, Merck Wilmington Biotech will also attract talented students and professionals, supporting community growth and development. The site’s proximity to Merck’s existing facilities ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/merck-breaks-ground-1-billion-104500898.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1983299246.USD","BK4516","LU1291159041.SGD","LU0208291251.USD","LU0122379950.USD","LU1116320737.USD","LU2023250504.SGD","SG9999001440.SGD","DM","LU1023059063.AUD","BK4559","HCC","CPS","BTC","LU2324357040.USD","HSCT","IE00B4R5TH58.HKD","LU1066051498.USD","SG9999015341.SGD","LU0265550946.USD","BK4585","LU1974910355.USD","LU1116320901.HKD","LU0965509010.AUD","LU1066053197.SGD","MRK","LU0861579265.USD","BK4588","CRC","CRT","LU0211331839.USD","LU0965508806.USD","LU0965509283.SGD","BK4161","RCC","LU1585245621.USD","LU1929549753.HKD","ALT","BK4135","LU2361045086.USD","IE00B2B36J28.USD","LU1069347547.HKD","BCG","IE00BJT1NW94.SGD","BK4533","LU0320765646.SGD","LU1066051811.HKD","LU2468319806.SGD","SG9999002224.SGD","LU1035773651.USD"],"gpt_icon":0},{"id":"2530548354","title":"KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2530548354","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530548354?lang=en_us&edition=fundamental","pubTime":"2025-04-28 00:00","pubTimestamp":1745769600,"startTime":"0","endTime":"0","summary":"KEYNOTE-689 marks the first positive trial in more than two decades for patients with resected locally advanced head and neck squamous cell carcinoma . Results to be presented at American Association for Cancer Research  Annual Meeting 2025 during a Plenary Session and included in official meeting press program. \"As the first positive trial in over two decades for patients with resectable, locally advanced head and neck squamous cell carcinoma, the presentation of these landmark results marks an important moment for these patients and those who care for them,\" said Dr. Ravindra Uppaluri, the study’s co-principal investigator, director of Head and Neck Surgical Oncology, Brigham and Women’s Hospital and Dana-Farber","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/keytruda-pembrolizumab-perioperative-treatment-standard-160000135.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1162221912.USD","BTC","LU1037948541.HKD","LU2298322129.HKD","IE0009355771.USD","SG9999014567.USD","SGXZ57979304.SGD","LU1854103824.USD","SG9999015358.SGD","LU0054578231.USD","LU0289739699.SGD","LU0861579265.USD","LU1934455194.USD","AEIS","ON","BK4605","LU1066051225.USD","CRT","LU0320765489.SGD","ITT","IE00B7SZL793.SGD","LU0265550946.USD","CRC","BK4097","LU2361044865.SGD","HCC","LU0320765646.SGD","SMP","ALT","LU2106854487.HKD","LU2361044949.HKD","HSCT","IE00BLSP4239.USD","LU0208291251.USD","OS","BK4161","LU1430594728.SGD","CPS","BK4533","IE00BZ199S13.USD","LU2023250843.SGD","BCG","MRK","LU1861220033.SGD","SG9999001440.SGD","IE00BLSP4452.SGD","SOC","RCC","DM","BK4135"],"gpt_icon":0},{"id":"2529938083","title":"Why Cross Timbers Royalty Trust (CRT) Is Losing This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2529938083","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529938083?lang=en_us&edition=fundamental","pubTime":"2025-04-24 19:24","pubTimestamp":1745493859,"startTime":"0","endTime":"0","summary":"We recently published a list ofEnergy Stocks that are Losing This Week. In this article, we are going to take a look at where Cross Timbers Royalty Trust  stands against other energy stocks that are crashing this week.After a promising start to the year, the overall energy sector has fallen by almost 5.5% since the beginning of 2025. However, it still beats the 9.9% decline suffered by the wider market. The major reason behind this downturn is the plunge in global crude oil price, caused by the continued uncertainty surrounding the ongoing tariff war, the prospects of an economic slowdown, and the recent decision by OPEC+ to increase supply in May.Cross Timbers Royalty Trust  declared its April cash dividend of $0.0321 per share last week, significantly lower than the $0.1567 per share cash distribution it announced in March. The company revealed that its oil sales volume declined by 36.8% from the previous month, while gas volume also decreased by around 19.6%. Moreover, the recent sl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-cross-timbers-royalty-trust-112419498.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CRT","BK4213"],"gpt_icon":0},{"id":"2529557053","title":"PennyMac Mortgage Investment Trust Reports First Quarter 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2529557053","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529557053?lang=en_us&edition=fundamental","pubTime":"2025-04-23 04:15","pubTimestamp":1745352900,"startTime":"0","endTime":"0","summary":"WESTLAKE VILLAGE, Calif., April 22, 2025----PennyMac Mortgage Investment Trust  today reported net loss attributable to common shareholders of $0.8 million, or $ per common share on a diluted basis for the first quarter of 2025, on net investment income of $44.5 million. PMT previously announced a cash dividend for the first quarter of 2025 of $0.40 per common share of beneficial interest, which was declared on March 6, 2025, and will be paid on April 25, 2025, to common shareholders of record as of April 11, 2025.Net loss attributable to common shareholders of $0.8 million; annualized return on average common equity of 0%1. \"PMT produced strong levels of income excluding market-driven value changes in the first quarter,\" said Chairman and CEO David Spector. \"This strong core performance was offset by net fair value declines due to interest rate volatility and credit spread widening. During the quarter, we opportunistically issued $173 million in unsecured senior notes, not only demons","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pennymac-mortgage-investment-trust-reports-201500895.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4229","PFSI","UPB","MBS","BK4195","BK4213","PMT","CRT","BK4139","BK4110","REIT"],"gpt_icon":0},{"id":"2528274805","title":"FDA Approves WiSE® System, World's First and Only Leadless Left Ventricular Endocardial Pacing (LVEP) Device for CRT","url":"https://stock-news.laohu8.com/highlight/detail?id=2528274805","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528274805?lang=en_us&edition=fundamental","pubTime":"2025-04-17 21:27","pubTimestamp":1744896420,"startTime":"0","endTime":"0","summary":"Every once in a while, a breakthrough doesn't just advance medicine—it changes the conversation entirely.\"Recent years have brought significant advancements in leadless pacing for the right heart, but CRT patients were limited to traditional options—until now,\" said principal investigator Niraj Varma, MD, PhD, FRCP, Professor of Medicine at Cleveland Clinic. \"Now, the WiSE System brings a leadless solution to left ventricular pacing, eliminating the biggest limitation of conventional CRT: the lead. This is a game-changer for patients who were previously untreatable due to anatomy or lead failures.\". Patients with challenging anatomy where the LV lead could not be implanted. Patients with high procedural risk for LV lead placement. Backed by Data. Reimagining Delivery of CRT.The SOLVE-CRT trial has delivered promising results for heart failure patients. The WiSE System offers hope to those who have tried other therapies without success and were told no further options existed—until now.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance_au","url":"https://finance.yahoo.com/news/fda-approves-wise-system-worlds-132700453.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-approves-wise-system-worlds-132700453.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["CRT","EBR.AU","BK4213","BK7007"],"gpt_icon":0},{"id":"2528716148","title":"Press Release: CROSS TIMBERS ROYALTY TRUST DECLARES APRIL CASH DISTRIBUTION","url":"https://stock-news.laohu8.com/highlight/detail?id=2528716148","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528716148?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:00","pubTimestamp":1744891200,"startTime":"0","endTime":"0","summary":"DALLAS, April 17, 2025 /PRNewswire/ -- Argent Trust Company, as Trustee of the Cross Timbers Royalty Trust  , today declared a cash distribution to the holders of its units of beneficial interest of $0.032110 per unit, payable on May 14, 2025, to unitholders of record on April 30, 2025. The following table shows underlying oil and gas sales and average prices attributable to the current month and prior month distributions.net profits income. Because of this, sales volumes may fluctuate from. In accordance with Section 3.08 of the Cross Timbers Royalty Trust Indenture, the Trustee has withheld $50,000 from this month's distribution to increase the amount of cash in the reserve account. The Trustee intends to continue to withhold $50,000 from distributable funds per month until the cash reserve has reached $1,500,000.For more information on the Trust, including the annual tax information, distribution amounts, and historical press releases, please visit our website at www.crt-crosstimber","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CASH","BK4213","CRT","BK4211"],"gpt_icon":0},{"id":"2527123886","title":"Which ASX company has just secured FDA approval?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527123886","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527123886?lang=en_us&edition=fundamental","pubTime":"2025-04-15 05:24","pubTimestamp":1744665847,"startTime":"0","endTime":"0","summary":"EBR Systems Inc (ASX: EBR) shares were in the spotlight on Monday when the medical device company released some big news. The ASX company revealed that it has received FDA approval for its WiSE CRT Sy","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/15/which-asx-company-has-just-secured-fda-approval/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4213","BK7007","EBR.AU","CRT"],"gpt_icon":0},{"id":"2527977273","title":"Australian Shares Rise Amidst Temporary Reprieve for Electronic Tariffs; EBR Systems Receives US FDA Approval for Heart Failure Treatment Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2527977273","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527977273?lang=en_us&edition=fundamental","pubTime":"2025-04-14 14:59","pubTimestamp":1744613994,"startTime":"0","endTime":"0","summary":"Australian shares rose on Monday after US President Trump temporarily exempted China from a 125% tariff on popular electronics and introduced flat 10% tariffs on electronics around the globe.The S&P/A","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","BK7501","XJO.AU","BK7007","WOW.AU","BK4081","XKO.AU","BK7511","IE00B1B80R65.USD","EBR.AU","CRT","BK7040","BK4213","BK7082","BK7096","NEU.AU","BK7508","COL.AU","EBR"],"gpt_icon":0},{"id":"2526840536","title":"U.S. Food and Drug Administration Approves Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a Treatment for Patients with Previously Untreated Microsatellite Instability-High or Mismatch Repair Deficient Unresectable or Metastatic Colorectal Cancer1","url":"https://stock-news.laohu8.com/highlight/detail?id=2526840536","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526840536?lang=en_us&edition=fundamental","pubTime":"2025-04-09 03:36","pubTimestamp":1744140960,"startTime":"0","endTime":"0","summary":"Based on the Phase 3 CheckMate-8HW trial, Opdivo plus Yervoy demonstrated reduction in the risk of disease progression or death by 79% vs. chemotherapy in the first-line setting and by 38% vs. Opdivo monotherapy across all lines of therapy 1. The approval was granted more than two months ahead of the Prescription Drug User Fee Act goal date. In the CheckMate-8HW trial, Opdivo plus Yervoy demonstrated a 38% reduction in the risk of disease progression or death vs. Opdivo monotherapy in immunotherapy-nave patients across all lines of therapy .1 Assessing the dual primary endpoint of PFS, the trial demonstrated that median PFS was not reached with Opdivo plus Yervoy  and was 39.3 months with Opdivo monotherapy .1 PFS rates at 12-, 24-, and 36-months were also numerically higher","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/u-food-drug-administration-approves-193600303.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1093756325.SGD","BK4195","LU0225284248.USD","LU1261432733.SGD","BK4532","CRC","LU0237698245.USD","LU1093756168.USD","LU0985481810.HKD","IE00BSNM7G36.USD","BK4581","ORR","LU1868837300.USD","OS","TEN","LU1868837136.USD","LU1670711040.USD","LU1323610961.USD","LU2133065610.SGD","LU2242652126.USD","BK4132","LU1074936037.SGD","LU0868494617.USD","IE00B2B36J28.USD","BK4006","IE00BFTCPJ56.SGD","VOD","LU1585245621.USD","HSCT","BK4211","IE0002141913.USD","BK4534","LU1670711123.USD","BMY","LU1718418525.SGD","BK4124","IE0009355771.USD","LU1032466523.USD","LU1868836757.USD","LU1989771016.USD","LU2242646821.SGD","LU0061475181.USD","LU1670710588.SGD","LU0114720955.EUR","LU1670710661.SGD","PFS","CRT","BK4144","HCC","LU0225771236.USD"],"gpt_icon":0},{"id":"2523491061","title":"IMFINZI® (durvalumab) approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2523491061","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523491061?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:00","pubTimestamp":1743418800,"startTime":"0","endTime":"0","summary":"Based on NIAGARA Phase III trial results which showed a 32% reduction in the risk of recurrence and a 25% reduction in the risk of death vs. neoadjuvant chemotherapy alone. WILMINGTON, Del., March 31, 2025----AstraZeneca’s IMFINZI  in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy  has been approved in the US for the treatment of adult patients with muscle-invasive bladder cancer .The approval was granted by the Food and Drug Administration  after securing Priority Review and was based on results from the NIAGARA Phase III trial which were presented during a Presidential Symposium at the 2024 European Society for Medical Oncology  Congress and simultaneously published in The New England Journal of Medicine.In the trial, patients were treated with four cycles of IMFI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/imfinzi-durvalumab-approved-us-first-110000141.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AZN","BK4006","TEN","LU1829250122.USD","LU2417539215.USD","BK4566","OS","BK4144","VOD","BK4097","BK4023","CRT","LU0889565916.HKD","IE00BFMHRM44.USD","BK4124","BK4585","LU2456880835.USD","HSCT","LU2236285917.USD","BK4568","LU0320765992.SGD","BK4532","NICE","BK4543","LU2462157665.USD","BK4007","LU0109394709.USD","BK4213","BK4132","BK4588","HCC"],"gpt_icon":0},{"id":"2522257316","title":"Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2522257316","media":"Business Wire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522257316?lang=en_us&edition=fundamental","pubTime":"2025-03-28 20:00","pubTimestamp":1743163200,"startTime":"0","endTime":"0","summary":"Recommendation is based primarily on results from the Phase 3 CheckMate -67T trial which demonstrated noninferiority in the co-primary endpoints of Cavgd28 and Cminss and consistent efficacy in the secondary endpoint of overall response rate for the subcutaneous formulation of Opdivo vs. its intravenous formulation. A decision on the EU Opdivo extension of marketing authorization is expected by June 2, 2025. \"The positive CHMP opinion is an important step forward in the evolution of immuno-oncology and in the potential of subcutaneous nivolumab to help transform the lives of people living with cancer,\" said Dana Walker, M.D., M.S.C.E., Opdivo global program lead, Bristol Myers Squibb. \"We look forward to bringing the same high-quality care that transformed cancer treatment with an administration method that has the potential to improve the patient experience and efficiency of healthcare systems in Europe.\"","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bristol-myers-squibb-receives-positive-120000105.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4500","LU1670711123.USD","ORR","EEA","LU1718418525.SGD","LU0061475181.USD","TEN","LU1074936037.SGD","LU1670711040.USD","LU0237698245.USD","LU1291159041.SGD","LU0306807586.USD","LU2133065610.SGD","BK4156","LU1670710661.SGD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU0882574055.USD","LU1032466523.USD","IE0002141913.USD","LU0321505439.SGD","UK","BK4528","LU2242652126.USD","LU1261432733.SGD","ALK","RCC","CRT","BK4559","BK4585","HSCT","IE0009355771.USD","BK4534","BK4532","BMY","LU0096364046.USD","MYE","LU0456855351.SGD","BK4008","LU1093756168.USD","BK4007","CHMP","LU0868494617.USD","EC","LU1093756325.SGD","LU1323610961.USD","LU1670710588.SGD","LU1868836914.USD","VOD"],"gpt_icon":0},{"id":"2522837332","title":"New study results reinforce TAGRISSO® (osimertinib) as the backbone therapy for EGFR-mutated lung cancer across stages and settings","url":"https://stock-news.laohu8.com/highlight/detail?id=2522837332","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522837332?lang=en_us&edition=fundamental","pubTime":"2025-03-26 07:02","pubTimestamp":1742943720,"startTime":"0","endTime":"0","summary":"SAVANNAH and ORCHARD Phase II trials show the addition of savolitinib or datopotamab deruxtecan-dlnk to TAGRISSO upon disease progression demonstrates strong clinical activity. WILMINGTON, Del., March 25, 2025----New study results presented at the European Lung Cancer Congress  2025, March 26 to 29, demonstrate the role of AstraZeneca’s TAGRISSO , as monotherapy and as the backbone for novel combinations, across stages and settings of epidermal growth factor receptor-mutated  non-small cell lung cancer . Highlights include:. LAURA Phase III trial of TAGRISSO in unresectable, Stage III EGFRm NSCLC after chemoradiotherapy  .SAVANNAH Phase II trial of TAGRISSO plus savolitinib in advanced EGFRm NSCLC with high levels of MET overexpression and/or amplification following disease progression on 1st-line TAGRISSO (#2O).FLAURA2 Phase III trial of TAGRISSO plus chemotherapy as 1st-line treatment for advanced EGFRm NSCLC .Professor Virginia Harrison, EGFR Positive UK, said: \"For people undergoin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/study-results-reinforce-tagrisso-osimertinib-230200995.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0889565916.HKD","BK4097","BK4007","BK4213","LU1829250122.USD","BK4568","BK4588","LU0320765992.SGD","BK4166","BK4144","ORR","BK4080","BK4124","QD","LU2462157665.USD","OS","LU2417539215.USD","BK4563","LU2456880835.USD","EMM","BK4211","BK4503","LU0109394709.USD","PFS","LU2236285917.USD","CRT","BK4585","TEN","BK4231","BK4195","ADC","AZN"],"gpt_icon":1},{"id":"2522886659","title":"EBR Systems Advances Towards FDA Approval and Market Launch of WiSE CRT System","url":"https://stock-news.laohu8.com/highlight/detail?id=2522886659","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522886659?lang=en_us&edition=fundamental","pubTime":"2025-03-26 01:58","pubTimestamp":1742925508,"startTime":"0","endTime":"0","summary":"EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( ($AU:EBR) ) has provided an announcement. EBR Systems, Inc. announced the submission o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ebr-systems-advances-towards-fda-approval-and-market-launch-of-wise-crt-system?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ebr-systems-advances-towards-fda-approval-and-market-launch-of-wise-crt-system?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRT","BK4213","EBR","IE00B1B80R65.USD","BK4081"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":47,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CRT\",params:#limit:5,,,undefined,":[{"date":"2025-05-30","symbol":"CRT","amount":0.0808,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-30","defaultRemindTime":1748611800000,"name":"CRT信托","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-13","payableDate":"2025-05-30","currency":"USD","dateTimestamp":1748577600000,"payDate":"2025-06-13"},{"market":"US","date":"2025-05-14","symbol":"CRT","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"","actualEps":0.3},{"date":"2025-04-30","symbol":"CRT","amount":0.03211,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-30","defaultRemindTime":1746019800000,"name":"CRT信托","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-14","payableDate":"2025-04-30","currency":"USD","dateTimestamp":1745985600000,"payDate":"2025-05-14"},{"date":"2025-03-31","symbol":"CRT","amount":0.156725,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-31","defaultRemindTime":1743427800000,"name":"CRT信托","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-14","payableDate":"2025-03-31","currency":"USD","dateTimestamp":1743393600000,"payDate":"2025-04-14"},{"market":"US","date":"2025-03-27","symbol":"CRT","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"post","actualEps":0.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CRT\",market:\"US\",,,undefined,":[{"executeDate":"2015-06-26","recordDate":"2015-06-30","paymentDate":"2015-07-14","value":0.080113,"currency":"USD"},{"executeDate":"2015-07-29","recordDate":"2015-07-31","paymentDate":"2015-08-14","value":0.099748,"currency":"USD"},{"executeDate":"2015-08-27","recordDate":"2015-08-31","paymentDate":"2015-09-15","value":0.099341,"currency":"USD"},{"executeDate":"2015-09-28","recordDate":"2015-09-30","paymentDate":"2015-10-15","value":0.094355,"currency":"USD"},{"executeDate":"2015-10-28","recordDate":"2015-10-30","paymentDate":"2015-11-16","value":0.102382,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CRT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CRT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CRT","date":"2025-06-13","current":10.082864,"percent":0.484947,"low":5.93557,"twenty":8.44973,"median":10.1767,"eighty":14.103137,"high":20.651413,"avg":11.084661,"sd":3.316408,"marketCap":60180000},"quantilePoints":[{"date":"2020-06-19","current":7.270743,"twenty":6.621907,"median":9.067856,"eighty":12.467109,"marketCap":43500000},{"date":"2020-06-26","current":7.361001,"twenty":6.672159,"median":9.067856,"eighty":12.467109,"marketCap":44040000},{"date":"2020-07-02","current":7.1504,"twenty":6.699118,"median":9.067856,"eighty":12.467109,"marketCap":42780000},{"date":"2020-07-10","current":6.689084,"twenty":6.710103,"median":9.067856,"eighty":12.467109,"marketCap":40020000},{"date":"2020-07-17","current":6.187653,"twenty":6.710103,"median":9.067856,"eighty":12.467109,"marketCap":37020000},{"date":"2020-07-24","current":6.614672,"twenty":6.710103,"median":9.067856,"eighty":12.467109,"marketCap":39574800},{"date":"2020-07-31","current":6.232782,"twenty":6.710103,"median":9.067856,"eighty":12.467109,"marketCap":37290000},{"date":"2020-08-07","current":6.368168,"twenty":6.710103,"median":9.067856,"eighty":12.467109,"marketCap":38100000},{"date":"2020-08-14","current":6.860703,"twenty":6.757678,"median":9.067856,"eighty":12.467109,"marketCap":36855600},{"date":"2020-08-21","current":6.768447,"twenty":6.771178,"median":9.067856,"eighty":12.467109,"marketCap":36360000},{"date":"2020-08-28","current":7.159363,"twenty":6.810956,"median":9.067856,"eighty":12.467109,"marketCap":38460000},{"date":"2020-09-04","current":6.835461,"twenty":6.821019,"median":9.067856,"eighty":12.467109,"marketCap":36720000},{"date":"2020-09-11","current":6.857799,"twenty":6.835587,"median":9.067856,"eighty":12.467109,"marketCap":36840000},{"date":"2020-09-18","current":6.768223,"twenty":6.858116,"median":9.067856,"eighty":12.467109,"marketCap":36358800},{"date":"2020-09-25","current":6.48922,"twenty":6.858116,"median":9.067856,"eighty":12.467109,"marketCap":34860000},{"date":"2020-10-02","current":6.098303,"twenty":6.858116,"median":9.067856,"eighty":12.467109,"marketCap":32760000},{"date":"2020-10-09","current":6.243278,"twenty":6.838644,"median":9.067856,"eighty":12.467109,"marketCap":33538800},{"date":"2020-10-16","current":6.511558,"twenty":6.835587,"median":9.067856,"eighty":12.467109,"marketCap":34980000},{"date":"2020-10-23","current":7.349237,"twenty":6.858116,"median":9.067856,"eighty":12.467109,"marketCap":39480000},{"date":"2020-10-30","current":8.209254,"twenty":6.878433,"median":9.067856,"eighty":12.467109,"marketCap":44100000},{"date":"2020-11-06","current":9.244814,"twenty":6.902826,"median":9.074987,"eighty":12.467109,"marketCap":44940000},{"date":"2020-11-13","current":10.330987,"twenty":6.924813,"median":9.120614,"eighty":12.467109,"marketCap":50220000},{"date":"2020-11-20","current":9.911329,"twenty":6.945184,"median":9.150702,"eighty":12.467109,"marketCap":48180000},{"date":"2020-11-27","current":10.232244,"twenty":6.96358,"median":9.162951,"eighty":12.467109,"marketCap":49740000},{"date":"2020-12-04","current":9.627443,"twenty":6.990733,"median":9.188359,"eighty":12.467109,"marketCap":46800000},{"date":"2020-12-11","current":9.849614,"twenty":7.015283,"median":9.202046,"eighty":12.467109,"marketCap":47880000},{"date":"2020-12-18","current":10.368015,"twenty":7.04534,"median":9.226016,"eighty":12.467109,"marketCap":50400000},{"date":"2020-12-24","current":10.491444,"twenty":7.072885,"median":9.248611,"eighty":12.467109,"marketCap":51000000},{"date":"2020-12-31","current":10.170529,"twenty":7.087866,"median":9.262892,"eighty":12.467109,"marketCap":49440000},{"date":"2021-01-08","current":10.392701,"twenty":7.129213,"median":9.27535,"eighty":12.467109,"marketCap":50520000},{"date":"2021-01-15","current":10.195215,"twenty":7.152193,"median":9.286268,"eighty":12.467109,"marketCap":49560000},{"date":"2021-01-22","current":10.244586,"twenty":7.172744,"median":9.299784,"eighty":12.467109,"marketCap":49800000},{"date":"2021-01-29","current":9.504014,"twenty":7.214589,"median":9.338988,"eighty":12.467109,"marketCap":46200000},{"date":"2021-02-05","current":10.021057,"twenty":7.229231,"median":9.355899,"eighty":12.467109,"marketCap":48713400},{"date":"2021-02-12","current":10.151027,"twenty":7.250221,"median":9.371894,"eighty":12.467109,"marketCap":49345200},{"date":"2021-02-19","current":11.096245,"twenty":7.270743,"median":9.409785,"eighty":12.467109,"marketCap":53940000},{"date":"2021-02-26","current":10.923445,"twenty":7.292398,"median":9.441362,"eighty":12.467109,"marketCap":53100000},{"date":"2021-03-05","current":11.355445,"twenty":7.34712,"median":9.497564,"eighty":12.468828,"marketCap":55200000},{"date":"2021-03-12","current":12.453961,"twenty":7.361001,"median":9.566299,"eighty":12.482371,"marketCap":60540000},{"date":"2021-03-19","current":11.269045,"twenty":7.408933,"median":9.622888,"eighty":12.482371,"marketCap":54780000},{"date":"2021-03-26","current":10.68893,"twenty":7.423035,"median":9.639786,"eighty":12.479662,"marketCap":51960000},{"date":"2021-04-01","current":10.60253,"twenty":7.49369,"median":9.656657,"eighty":12.479662,"marketCap":51540000},{"date":"2021-04-09","current":11.071559,"twenty":7.531804,"median":9.703447,"eighty":12.482371,"marketCap":53820000},{"date":"2021-04-16","current":11.140889,"twenty":7.556966,"median":9.750871,"eighty":12.482371,"marketCap":52080000},{"date":"2021-04-23","current":12.180534,"twenty":7.571602,"median":9.766899,"eighty":12.482371,"marketCap":56940000},{"date":"2021-04-30","current":12.616928,"twenty":7.615202,"median":9.806414,"eighty":12.494608,"marketCap":58980000},{"date":"2021-05-07","current":13.078992,"twenty":7.682222,"median":9.841907,"eighty":12.503201,"marketCap":61140000},{"date":"2021-05-14","current":15.610404,"twenty":7.717157,"median":9.883983,"eighty":12.526935,"marketCap":60960000},{"date":"2021-05-21","current":15.164831,"twenty":7.782203,"median":9.913169,"eighty":12.536097,"marketCap":59220000},{"date":"2021-05-28","current":14.965092,"twenty":7.824611,"median":9.944313,"eighty":12.546167,"marketCap":58440000},{"date":"2021-06-04","current":15.287748,"twenty":7.872851,"median":9.971976,"eighty":12.563354,"marketCap":59700000},{"date":"2021-06-11","current":15.441393,"twenty":7.880546,"median":9.985386,"eighty":12.571947,"marketCap":60300000},{"date":"2021-06-18","current":15.56431,"twenty":7.893169,"median":10.010072,"eighty":12.587481,"marketCap":60780000},{"date":"2021-06-25","current":18.667953,"twenty":7.939412,"median":10.034758,"eighty":12.598778,"marketCap":72900000},{"date":"2021-07-02","current":17.223684,"twenty":7.951639,"median":10.096472,"eighty":12.615118,"marketCap":67260000},{"date":"2021-07-09","current":17.607798,"twenty":7.960357,"median":10.108815,"eighty":12.630808,"marketCap":68760000},{"date":"2021-07-16","current":17.377329,"twenty":7.960357,"median":10.145843,"eighty":12.639613,"marketCap":67860000},{"date":"2021-07-23","current":19.174984,"twenty":7.98167,"median":10.167447,"eighty":12.659667,"marketCap":74880000},{"date":"2021-07-30","current":18.775505,"twenty":7.995539,"median":10.182872,"eighty":12.68366,"marketCap":73320000},{"date":"2021-08-06","current":17.822902,"twenty":8.009454,"median":10.199165,"eighty":12.711966,"marketCap":69600000},{"date":"2021-08-13","current":16.150292,"twenty":8.009454,"median":10.234666,"eighty":12.756936,"marketCap":72120000},{"date":"2021-08-20","current":15.263504,"twenty":8.009454,"median":10.256929,"eighty":12.783365,"marketCap":68160000},{"date":"2021-08-27","current":16.365271,"twenty":8.009454,"median":10.287786,"eighty":12.818164,"marketCap":73080000},{"date":"2021-09-03","current":16.926634,"twenty":8.009454,"median":10.331402,"eighty":12.833711,"marketCap":75586800},{"date":"2021-09-10","current":16.123419,"twenty":8.009454,"median":10.374187,"eighty":12.854872,"marketCap":72000000},{"date":"2021-09-17","current":17.440165,"twenty":8.009454,"median":10.417731,"eighty":12.882425,"marketCap":77880000},{"date":"2021-09-24","current":19.240614,"twenty":8.009454,"median":10.504955,"eighty":12.917553,"marketCap":85920000},{"date":"2021-10-01","current":19.106252,"twenty":8.009454,"median":10.583661,"eighty":12.944662,"marketCap":85320000},{"date":"2021-10-08","current":20.651413,"twenty":8.009454,"median":10.62548,"eighty":12.95853,"marketCap":92220000},{"date":"2021-10-15","current":20.328945,"twenty":8.009454,"median":10.662788,"eighty":12.983815,"marketCap":90780000},{"date":"2021-10-22","current":18.461315,"twenty":8.009454,"median":10.691788,"eighty":13.049275,"marketCap":82440000},{"date":"2021-10-29","current":18.434443,"twenty":8.009707,"median":10.732305,"eighty":13.08048,"marketCap":82320000},{"date":"2021-11-05","current":19.227178,"twenty":8.009707,"median":10.742312,"eighty":13.162363,"marketCap":85860000},{"date":"2021-11-12","current":13.602537,"twenty":8.009707,"median":10.792834,"eighty":13.230652,"marketCap":83700000},{"date":"2021-11-19","current":11.067297,"twenty":8.009707,"median":10.807619,"eighty":13.238255,"marketCap":68100000},{"date":"2021-11-26","current":11.896125,"twenty":8.009707,"median":10.807619,"eighty":13.238255,"marketCap":73200000},{"date":"2021-12-03","current":9.750922,"twenty":8.009707,"median":10.807619,"eighty":13.238255,"marketCap":60000000},{"date":"2021-12-10","current":10.696762,"twenty":8.009707,"median":10.739836,"eighty":13.238255,"marketCap":65820000},{"date":"2021-12-17","current":10.277472,"twenty":8.009707,"median":10.717242,"eighty":13.238255,"marketCap":63240000},{"date":"2021-12-23","current":11.31107,"twenty":8.009707,"median":10.717242,"eighty":13.238255,"marketCap":69600000},{"date":"2021-12-31","current":11.174557,"twenty":8.009707,"median":10.717242,"eighty":13.238255,"marketCap":68760000},{"date":"2022-01-07","current":11.769363,"twenty":8.009961,"median":10.721601,"eighty":13.234818,"marketCap":72420000},{"date":"2022-01-14","current":13.066236,"twenty":8.009961,"median":10.721601,"eighty":13.234818,"marketCap":80400000},{"date":"2022-01-21","current":13.10524,"twenty":8.009961,"median":10.721601,"eighty":13.258494,"marketCap":80640000},{"date":"2022-01-28","current":13.446522,"twenty":8.009961,"median":10.721601,"eighty":13.281823,"marketCap":82740000},{"date":"2022-02-04","current":14.528874,"twenty":8.009961,"median":10.721601,"eighty":13.31505,"marketCap":89400000},{"date":"2022-02-11","current":14.558127,"twenty":8.009961,"median":10.736902,"eighty":13.338305,"marketCap":89580000},{"date":"2022-02-18","current":14.236347,"twenty":8.009961,"median":10.749664,"eighty":13.393471,"marketCap":87600000},{"date":"2022-02-25","current":14.894534,"twenty":8.009961,"median":10.830284,"eighty":13.417826,"marketCap":91650000},{"date":"2022-03-04","current":15.484465,"twenty":8.009961,"median":10.946951,"eighty":13.471216,"marketCap":95280000},{"date":"2022-03-11","current":15.845249,"twenty":8.009961,"median":10.986766,"eighty":13.51972,"marketCap":97500000},{"date":"2022-03-18","current":14.314354,"twenty":8.009961,"median":11.077731,"eighty":13.580741,"marketCap":88080000},{"date":"2022-03-25","current":13.573284,"twenty":8.009961,"median":11.122435,"eighty":13.603533,"marketCap":83520000},{"date":"2022-04-01","current":11.814241,"twenty":8.009961,"median":11.145616,"eighty":13.603533,"marketCap":78840000},{"date":"2022-04-08","current":12.092964,"twenty":8.009961,"median":11.211742,"eighty":13.603533,"marketCap":80700000},{"date":"2022-04-14","current":12.362695,"twenty":8.009961,"median":11.256702,"eighty":13.603533,"marketCap":82500000},{"date":"2022-04-22","current":13.369693,"twenty":8.009961,"median":11.319498,"eighty":13.614314,"marketCap":89220000},{"date":"2022-04-29","current":13.468595,"twenty":8.009961,"median":11.352759,"eighty":13.641654,"marketCap":89880000},{"date":"2022-05-06","current":14.250816,"twenty":8.009961,"median":11.413684,"eighty":13.675545,"marketCap":95100000},{"date":"2022-05-13","current":12.993784,"twenty":8.009961,"median":11.413684,"eighty":13.70999,"marketCap":95100000},{"date":"2022-05-20","current":15.010485,"twenty":8.009961,"median":11.413684,"eighty":13.753017,"marketCap":109860000},{"date":"2022-05-27","current":15.641729,"twenty":8.009961,"median":11.413684,"eighty":13.801264,"marketCap":114480000},{"date":"2022-06-03","current":14.567795,"twenty":8.009961,"median":11.413684,"eighty":13.826646,"marketCap":106620000},{"date":"2022-06-10","current":15.79749,"twenty":8.009961,"median":11.413684,"eighty":13.873668,"marketCap":115620000},{"date":"2022-06-17","current":14.297262,"twenty":8.009961,"median":11.413684,"eighty":13.874468,"marketCap":104640000},{"date":"2022-06-24","current":14.059521,"twenty":8.009707,"median":11.410988,"eighty":13.897974,"marketCap":102900000},{"date":"2022-07-01","current":12.387134,"twenty":8.009707,"median":11.410988,"eighty":13.933076,"marketCap":90660000},{"date":"2022-07-08","current":11.928048,"twenty":8.009707,"median":11.398828,"eighty":13.933076,"marketCap":87300000},{"date":"2022-07-15","current":13.059368,"twenty":8.009707,"median":11.398828,"eighty":13.933076,"marketCap":95580000},{"date":"2022-07-22","current":13.993937,"twenty":8.009707,"median":11.398828,"eighty":13.954875,"marketCap":102420000},{"date":"2022-07-29","current":15.010485,"twenty":8.009707,"median":11.398828,"eighty":13.979654,"marketCap":109860000},{"date":"2022-08-05","current":14.567795,"twenty":8.009707,"median":11.398828,"eighty":14.001242,"marketCap":106620000},{"date":"2022-08-12","current":12.549381,"twenty":8.009707,"median":11.398828,"eighty":14.029636,"marketCap":115560000},{"date":"2022-08-19","current":12.823044,"twenty":8.009707,"median":11.398828,"eighty":14.029636,"marketCap":118080000},{"date":"2022-08-26","current":14.72565,"twenty":8.009707,"median":11.398828,"eighty":14.055815,"marketCap":135600000},{"date":"2022-09-02","current":13.298695,"twenty":8.009707,"median":11.398828,"eighty":14.084883,"marketCap":122460000},{"date":"2022-09-09","current":14.09362,"twenty":8.009707,"median":11.398828,"eighty":14.09169,"marketCap":129780000},{"date":"2022-09-16","current":14.393346,"twenty":8.009707,"median":11.398828,"eighty":14.141203,"marketCap":132540000},{"date":"2022-09-23","current":11.500342,"twenty":8.009707,"median":11.398828,"eighty":14.141203,"marketCap":105900000},{"date":"2022-09-30","current":12.575445,"twenty":8.009707,"median":11.355445,"eighty":14.141203,"marketCap":115800000},{"date":"2022-10-07","current":15.051439,"twenty":8.009707,"median":11.355445,"eighty":14.215272,"marketCap":138600000},{"date":"2022-10-14","current":13.865568,"twenty":8.009707,"median":11.355445,"eighty":14.215272,"marketCap":127680000},{"date":"2022-10-21","current":14.764745,"twenty":8.009707,"median":11.355445,"eighty":14.245895,"marketCap":135960000},{"date":"2022-10-28","current":15.038407,"twenty":8.009707,"median":11.355445,"eighty":14.280469,"marketCap":138480000},{"date":"2022-11-04","current":13.318243,"twenty":8.009707,"median":11.355445,"eighty":14.280469,"marketCap":122640000},{"date":"2022-11-11","current":14.080588,"twenty":8.009707,"median":11.355445,"eighty":14.280469,"marketCap":129660000},{"date":"2022-11-18","current":11.855702,"twenty":8.009707,"median":11.355445,"eighty":14.280469,"marketCap":126180000},{"date":"2022-11-25","current":12.566029,"twenty":8.009707,"median":11.355445,"eighty":14.280469,"marketCap":133740000},{"date":"2022-12-02","current":14.048697,"twenty":8.009707,"median":11.355445,"eighty":14.280469,"marketCap":149520000},{"date":"2022-12-09","current":12.340529,"twenty":8.009707,"median":11.355445,"eighty":14.280469,"marketCap":131340000},{"date":"2022-12-16","current":12.374354,"twenty":8.009707,"median":11.355445,"eighty":14.280469,"marketCap":131700000},{"date":"2022-12-23","current":14.116347,"twenty":8.009707,"median":11.355445,"eighty":14.280469,"marketCap":150240000},{"date":"2022-12-30","current":14.341848,"twenty":8.009707,"median":11.355445,"eighty":14.300488,"marketCap":152640000},{"date":"2023-01-06","current":13.394745,"twenty":8.009707,"median":11.355445,"eighty":14.298116,"marketCap":142560000},{"date":"2023-01-13","current":13.930309,"twenty":8.009707,"median":11.355445,"eighty":14.255346,"marketCap":148260000},{"date":"2023-01-20","current":14.392586,"twenty":8.009707,"median":11.355445,"eighty":14.237759,"marketCap":153180000},{"date":"2023-01-27","current":15.142376,"twenty":8.009707,"median":11.355445,"eighty":14.237759,"marketCap":161160000},{"date":"2023-02-03","current":14.747749,"twenty":8.009707,"median":11.355445,"eighty":14.255346,"marketCap":156960000},{"date":"2023-02-10","current":15.531364,"twenty":8.009707,"median":11.355445,"eighty":14.299207,"marketCap":165300000},{"date":"2023-02-17","current":15.046538,"twenty":8.009707,"median":11.355445,"eighty":14.346809,"marketCap":160140000},{"date":"2023-02-24","current":11.461076,"twenty":8.009707,"median":11.355445,"eighty":14.307017,"marketCap":121980000},{"date":"2023-03-03","current":10.637998,"twenty":8.009707,"median":11.330572,"eighty":14.275418,"marketCap":113220000},{"date":"2023-03-10","current":9.08768,"twenty":8.009707,"median":11.297163,"eighty":14.263524,"marketCap":96720000},{"date":"2023-03-17","current":7.616288,"twenty":8.006501,"median":11.244359,"eighty":14.219343,"marketCap":81060000},{"date":"2023-03-24","current":9.335731,"twenty":7.99797,"median":11.166559,"eighty":14.118602,"marketCap":99360000},{"date":"2023-03-31","current":9.554436,"twenty":8.000401,"median":11.139946,"eighty":14.077625,"marketCap":112200000},{"date":"2023-04-06","current":9.83034,"twenty":8.000401,"median":11.112498,"eighty":14.050862,"marketCap":115440000},{"date":"2023-04-14","current":10.004057,"twenty":7.995539,"median":11.084934,"eighty":14.055191,"marketCap":117480000},{"date":"2023-04-21","current":10.893079,"twenty":7.995539,"median":10.989993,"eighty":14.055191,"marketCap":127920000},{"date":"2023-04-28","current":10.673378,"twenty":7.995539,"median":10.986766,"eighty":14.055191,"marketCap":125340000},{"date":"2023-05-05","current":10.305507,"twenty":7.993108,"median":10.958248,"eighty":14.057356,"marketCap":121020000},{"date":"2023-05-12","current":10.770455,"twenty":7.993108,"median":10.852808,"eighty":14.057356,"marketCap":126480000},{"date":"2023-05-19","current":8.852709,"twenty":7.993108,"median":10.807619,"eighty":14.057356,"marketCap":121260000},{"date":"2023-05-26","current":9.299506,"twenty":7.993108,"median":10.746539,"eighty":14.057356,"marketCap":127380000},{"date":"2023-06-02","current":9.10677,"twenty":7.993108,"median":10.725959,"eighty":14.057356,"marketCap":124740000},{"date":"2023-06-09","current":10.469062,"twenty":7.993108,"median":10.694647,"eighty":14.057356,"marketCap":143400000},{"date":"2023-06-16","current":11.1743,"twenty":7.993108,"median":10.679585,"eighty":14.057356,"marketCap":153060000},{"date":"2023-06-23","current":9.553567,"twenty":7.990677,"median":10.672528,"eighty":14.059521,"marketCap":130860000},{"date":"2023-06-30","current":9.908376,"twenty":7.990677,"median":10.622285,"eighty":14.062431,"marketCap":135720000},{"date":"2023-07-07","current":9.281984,"twenty":7.990677,"median":10.565501,"eighty":14.062431,"marketCap":127140000},{"date":"2023-07-14","current":8.440955,"twenty":7.990677,"median":10.513893,"eighty":14.062431,"marketCap":115620000},{"date":"2023-07-21","current":8.546084,"twenty":7.990677,"median":10.454415,"eighty":14.062431,"marketCap":117060000},{"date":"2023-07-28","current":9.067347,"twenty":7.990677,"median":10.39339,"eighty":14.062431,"marketCap":124200000},{"date":"2023-08-04","current":9.067347,"twenty":7.990677,"median":10.373035,"eighty":14.062431,"marketCap":124200000},{"date":"2023-08-11","current":8.953457,"twenty":7.990677,"median":10.355733,"eighty":14.062431,"marketCap":122640000},{"date":"2023-08-18","current":9.683499,"twenty":7.990677,"median":10.316476,"eighty":14.062431,"marketCap":127620000},{"date":"2023-08-25","current":9.159944,"twenty":7.990677,"median":10.269272,"eighty":14.062431,"marketCap":120720000},{"date":"2023-09-01","current":9.455867,"twenty":7.990677,"median":10.241637,"eighty":14.065342,"marketCap":124620000},{"date":"2023-09-08","current":9.264655,"twenty":7.990677,"median":10.22431,"eighty":14.065342,"marketCap":122100000},{"date":"2023-09-15","current":10.289003,"twenty":7.990677,"median":10.191603,"eighty":14.065342,"marketCap":135600000},{"date":"2023-09-22","current":8.909548,"twenty":7.990677,"median":10.170529,"eighty":14.065342,"marketCap":117420000},{"date":"2023-09-29","current":9.146286,"twenty":7.990677,"median":10.152227,"eighty":14.065342,"marketCap":120540000},{"date":"2023-10-06","current":8.39965,"twenty":7.990677,"median":10.143374,"eighty":14.065342,"marketCap":110700000},{"date":"2023-10-13","current":8.581757,"twenty":7.990677,"median":10.10424,"eighty":14.065342,"marketCap":113100000},{"date":"2023-10-20","current":8.404203,"twenty":7.990677,"median":10.055124,"eighty":14.065342,"marketCap":110760000},{"date":"2023-10-27","current":8.135596,"twenty":7.990677,"median":10.034758,"eighty":14.074073,"marketCap":107220000},{"date":"2023-11-03","current":8.422414,"twenty":7.990677,"median":10.010072,"eighty":14.074073,"marketCap":111000000},{"date":"2023-11-10","current":8.24486,"twenty":7.990677,"median":9.985386,"eighty":14.074073,"marketCap":108660000},{"date":"2023-11-17","current":9.372752,"twenty":7.990677,"median":9.962963,"eighty":14.074073,"marketCap":111480000},{"date":"2023-11-24","current":10.184923,"twenty":7.990677,"median":9.948357,"eighty":14.074073,"marketCap":121140000},{"date":"2023-12-01","current":9.468598,"twenty":7.990677,"median":9.932561,"eighty":14.074073,"marketCap":112620000},{"date":"2023-12-08","current":9.519044,"twenty":7.990677,"median":9.911329,"eighty":14.071163,"marketCap":113220000},{"date":"2023-12-15","current":9.100347,"twenty":7.990677,"median":9.884038,"eighty":14.071163,"marketCap":108240000},{"date":"2023-12-22","current":9.266817,"twenty":7.990677,"median":9.870083,"eighty":14.071163,"marketCap":110220000},{"date":"2023-12-29","current":8.974234,"twenty":7.990677,"median":9.871214,"eighty":14.074073,"marketCap":106740000},{"date":"2024-01-05","current":8.933877,"twenty":7.990091,"median":9.876268,"eighty":14.074635,"marketCap":106260000},{"date":"2024-01-12","current":8.827942,"twenty":7.990091,"median":9.876268,"eighty":14.074635,"marketCap":105000000},{"date":"2024-01-19","current":8.550492,"twenty":7.989505,"median":9.868953,"eighty":14.075197,"marketCap":101700000},{"date":"2024-01-26","current":9.12557,"twenty":7.990091,"median":9.862382,"eighty":14.074635,"marketCap":108540000},{"date":"2024-02-02","current":9.01459,"twenty":7.990091,"median":9.862382,"eighty":14.074635,"marketCap":107220000},{"date":"2024-02-09","current":8.653098,"twenty":7.990091,"median":9.862382,"eighty":14.074635,"marketCap":102920400},{"date":"2024-02-16","current":8.807764,"twenty":7.990091,"median":9.862382,"eighty":14.074635,"marketCap":104760000},{"date":"2024-02-23","current":8.752274,"twenty":7.990091,"median":9.862382,"eighty":14.074635,"marketCap":104100000},{"date":"2024-03-01","current":8.621116,"twenty":7.990677,"median":9.855812,"eighty":14.074073,"marketCap":102540000},{"date":"2024-03-08","current":8.460195,"twenty":7.990677,"median":9.855812,"eighty":14.074073,"marketCap":100626000},{"date":"2024-03-15","current":8.716962,"twenty":7.990677,"median":9.855812,"eighty":14.074073,"marketCap":103680000},{"date":"2024-03-22","current":6.366207,"twenty":7.967059,"median":9.855812,"eighty":14.074073,"marketCap":75720000},{"date":"2024-03-28","current":6.608345,"twenty":7.950304,"median":9.855812,"eighty":14.074073,"marketCap":78600000},{"date":"2024-04-05","current":7.138968,"twenty":7.941228,"median":9.862382,"eighty":14.074635,"marketCap":82440000},{"date":"2024-04-12","current":6.910355,"twenty":7.889973,"median":9.862382,"eighty":14.074635,"marketCap":79800000},{"date":"2024-04-19","current":6.827222,"twenty":7.844425,"median":9.862382,"eighty":14.074635,"marketCap":78840000},{"date":"2024-04-26","current":7.502671,"twenty":7.795306,"median":9.855812,"eighty":14.074073,"marketCap":86640000},{"date":"2024-05-03","current":6.894767,"twenty":7.726926,"median":9.855812,"eighty":14.074073,"marketCap":79620000},{"date":"2024-05-10","current":7.149359,"twenty":7.682222,"median":9.855812,"eighty":14.074073,"marketCap":82560000},{"date":"2024-05-17","current":8.966269,"twenty":7.640335,"median":9.83829,"eighty":14.074073,"marketCap":84300000},{"date":"2024-05-24","current":8.729508,"twenty":7.640335,"median":9.831805,"eighty":14.074073,"marketCap":82074000},{"date":"2024-05-31","current":9.135384,"twenty":7.640335,"median":9.831805,"eighty":14.074073,"marketCap":85890000},{"date":"2024-06-07","current":8.570604,"twenty":7.640335,"median":9.831805,"eighty":14.074073,"marketCap":80580000},{"date":"2024-06-14","current":8.398299,"twenty":7.638623,"median":9.834885,"eighty":14.074635,"marketCap":78960000},{"date":"2024-06-21","current":6.892221,"twenty":7.624059,"median":9.837965,"eighty":14.075197,"marketCap":64800000},{"date":"2024-06-28","current":6.707152,"twenty":7.615202,"median":9.831072,"eighty":14.076884,"marketCap":63060000},{"date":"2024-07-05","current":6.209381,"twenty":7.583787,"median":9.797365,"eighty":14.076884,"marketCap":58380000},{"date":"2024-07-12","current":6.05622,"twenty":7.549432,"median":9.790107,"eighty":14.076884,"marketCap":56940000},{"date":"2024-07-15","current":6.566755,"twenty":7.541516,"median":9.790107,"eighty":14.076884,"marketCap":61740000},{"date":"2024-08-02","current":6.483793,"twenty":7.526694,"median":9.849614,"eighty":14.097348,"marketCap":60960000},{"date":"2024-08-09","current":6.362541,"twenty":7.500185,"median":9.849614,"eighty":14.097348,"marketCap":59820000},{"date":"2024-08-16","current":8.330038,"twenty":7.484922,"median":9.849614,"eighty":14.097348,"marketCap":64200000},{"date":"2024-08-23","current":7.921321,"twenty":7.484922,"median":9.849614,"eighty":14.097348,"marketCap":61050000},{"date":"2024-08-30","current":7.699446,"twenty":7.484922,"median":9.849614,"eighty":14.097348,"marketCap":59340000},{"date":"2024-09-06","current":7.119457,"twenty":7.435611,"median":9.849614,"eighty":14.097348,"marketCap":54870000},{"date":"2024-09-13","current":7.15449,"twenty":7.407031,"median":9.849614,"eighty":14.097348,"marketCap":55140000},{"date":"2024-09-20","current":7.240126,"twenty":7.361001,"median":9.849614,"eighty":14.097348,"marketCap":55800000},{"date":"2024-09-27","current":8.080915,"twenty":7.361001,"median":9.849614,"eighty":14.097348,"marketCap":62280000},{"date":"2024-10-04","current":8.392318,"twenty":7.407031,"median":9.849614,"eighty":14.097348,"marketCap":64680000},{"date":"2024-10-11","current":8.115948,"twenty":7.435611,"median":9.849614,"eighty":14.097348,"marketCap":62550000},{"date":"2024-10-18","current":8.610301,"twenty":7.490676,"median":9.849614,"eighty":14.097348,"marketCap":66360000},{"date":"2024-10-25","current":8.485739,"twenty":7.521459,"median":9.849614,"eighty":14.097348,"marketCap":65400000},{"date":"2024-10-31","current":8.174336,"twenty":7.534577,"median":9.849614,"eighty":14.097348,"marketCap":63000000},{"date":"2024-11-08","current":7.715016,"twenty":7.56266,"median":9.849614,"eighty":14.098591,"marketCap":59460000},{"date":"2024-11-15","current":8.879894,"twenty":7.56266,"median":9.849614,"eighty":14.098591,"marketCap":60180000},{"date":"2024-11-22","current":9.827201,"twenty":7.56266,"median":9.849614,"eighty":14.098591,"marketCap":66600000},{"date":"2024-11-29","current":9.685547,"twenty":7.56266,"median":9.849614,"eighty":14.098591,"marketCap":65640000},{"date":"2024-12-06","current":8.959574,"twenty":7.56266,"median":9.849614,"eighty":14.098591,"marketCap":60720000},{"date":"2024-12-13","current":8.986134,"twenty":7.586268,"median":9.849614,"eighty":14.098591,"marketCap":60900000},{"date":"2024-12-20","current":8.277867,"twenty":7.640637,"median":9.849614,"eighty":14.098591,"marketCap":56100000},{"date":"2024-12-27","current":8.764801,"twenty":7.70256,"median":9.849614,"eighty":14.098591,"marketCap":59400000},{"date":"2025-01-03","current":8.844481,"twenty":7.70256,"median":9.849614,"eighty":14.098591,"marketCap":59940000},{"date":"2025-01-10","current":8.729387,"twenty":7.699446,"median":9.849614,"eighty":14.099834,"marketCap":59160000},{"date":"2025-01-17","current":9.145494,"twenty":7.699446,"median":9.849614,"eighty":14.099834,"marketCap":61980000},{"date":"2025-01-24","current":9.836054,"twenty":7.699446,"median":9.849614,"eighty":14.099834,"marketCap":66660000},{"date":"2025-01-31","current":9.473067,"twenty":7.699446,"median":9.849614,"eighty":14.099834,"marketCap":64200000},{"date":"2025-02-07","current":9.402241,"twenty":7.715016,"median":9.849614,"eighty":14.099834,"marketCap":63720000},{"date":"2025-02-14","current":9.366827,"twenty":7.715016,"median":9.849614,"eighty":14.099834,"marketCap":63480000},{"date":"2025-02-21","current":9.729814,"twenty":7.715016,"median":9.855812,"eighty":14.099834,"marketCap":65940000},{"date":"2025-02-28","current":9.579307,"twenty":7.715016,"median":9.855812,"eighty":14.099834,"marketCap":64920000},{"date":"2025-03-07","current":9.437654,"twenty":7.811551,"median":9.862382,"eighty":14.103137,"marketCap":63960000},{"date":"2025-03-14","current":9.517334,"twenty":7.856705,"median":9.862382,"eighty":14.103137,"marketCap":64500000},{"date":"2025-03-21","current":9.836054,"twenty":7.920558,"median":9.862382,"eighty":14.103137,"marketCap":66660000},{"date":"2025-03-28","current":12.427309,"twenty":7.995093,"median":9.897835,"eighty":14.103137,"marketCap":70560000},{"date":"2025-04-04","current":12.532984,"twenty":8.041719,"median":9.940527,"eighty":14.103137,"marketCap":71160000},{"date":"2025-04-11","current":10.778789,"twenty":8.097564,"median":9.977707,"eighty":14.099834,"marketCap":61200000},{"date":"2025-04-17","current":11.465672,"twenty":8.121938,"median":10.010072,"eighty":14.099834,"marketCap":65100000},{"date":"2025-04-25","current":10.736519,"twenty":8.165725,"median":10.052751,"eighty":14.103137,"marketCap":60960000},{"date":"2025-05-02","current":10.683682,"twenty":8.206941,"median":10.102643,"eighty":14.103137,"marketCap":60660000},{"date":"2025-05-09","current":10.662547,"twenty":8.277402,"median":10.141401,"eighty":14.103137,"marketCap":60540000},{"date":"2025-05-16","current":10.052706,"twenty":8.346918,"median":10.148867,"eighty":14.103137,"marketCap":60000000},{"date":"2025-05-23","current":10.273866,"twenty":8.382072,"median":10.162866,"eighty":14.103137,"marketCap":61320000},{"date":"2025-05-30","current":10.113023,"twenty":8.39938,"median":10.1767,"eighty":14.103137,"marketCap":60360000},{"date":"2025-06-06","current":9.801389,"twenty":8.419509,"median":10.1767,"eighty":14.103137,"marketCap":58500000},{"date":"2025-06-13","current":10.082864,"twenty":8.44973,"median":10.1767,"eighty":14.103137,"marketCap":60180000}],"updateTime":1749975460239}}}